Profile
| Metric | Value |
|---|---|
| Full Name | Estrella Immunopharma, Inc. |
| Ticker | NASDAQ: ESLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | estrellabio.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.20 | ||
| Price, 1D Change | +15.38% | |
| $45M | ||
| - | ||
| - | ||
| 0.42 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.24 | ||
| EPS, 1Y Change | +10.12% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | UPTD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.24 | ||
| EPS Estimate | N/A | -$0.46 |
| EPS Est. Change | N/A | -89.69% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.20 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +566.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.46 | N/A | - | |
| -$0.75 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +9.59% | ||
| -88.73% | ||
| +14.35% | ||
| +82.64% | ||
| - | ||
| 0.00% | ||
| -100.00% | ||
| -471.93% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.20 | ||
| $1.29 | ||
| SMA 200 vs Price | +7.15% | |
| $1.45 | ||
| SMA 50 vs Price | +20.97% | |
| 0.42 | ||
| $0.15 | ||
| 40.93 | ||
| 86.47% | ||
| 110.97% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.24 | ||
| $0.00 | ||
| - | ||
| -$8.85M | ||
| - | ||
| -$8.85M | ||
| - | ||
| -$8.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 0.55 | ||
| 0.55 | ||
| - | ||
| - | ||
| -11.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -4.61 | ||
| -3.24 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $143.70K | ||
| $916.90K | ||
| $3.14M | ||
| $1.64M | ||
| $3.00M | ||
| $3.00M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $8.85M | ||
| $8.85M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $100.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$3.11M | ||
| $0.00 | ||
| -$135.00K | ||
| $0.00 | ||
| -$3.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital |
Analyst sentiment
Institutional ownership
Screeners with ESLA
FAQ
What is the ticker symbol for Estrella Immunopharma, Inc.?
The ticker symbol for Estrella Immunopharma, Inc. is NASDAQ:ESLA
Does Estrella Immunopharma, Inc. pay dividends?
No, Estrella Immunopharma, Inc. does not pay dividends
What sector is Estrella Immunopharma, Inc. in?
Estrella Immunopharma, Inc. is in the Healthcare sector
What industry is Estrella Immunopharma, Inc. in?
Estrella Immunopharma, Inc. is in the Biotechnology industry
What country is Estrella Immunopharma, Inc. based in?
Estrella Immunopharma, Inc. is headquartered in United States
When did Estrella Immunopharma, Inc. go public?
Estrella Immunopharma, Inc. initial public offering (IPO) was on September 14, 2021
Is Estrella Immunopharma, Inc. in the S&P 500?
No, Estrella Immunopharma, Inc. is not included in the S&P 500 index
Is Estrella Immunopharma, Inc. in the NASDAQ 100?
No, Estrella Immunopharma, Inc. is not included in the NASDAQ 100 index
Is Estrella Immunopharma, Inc. in the Dow Jones?
No, Estrella Immunopharma, Inc. is not included in the Dow Jones index
When was Estrella Immunopharma, Inc. last earnings report?
Estrella Immunopharma, Inc.'s most recent earnings report was on September 26, 2025
When does Estrella Immunopharma, Inc. report earnings?
The date for Estrella Immunopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ESLA Official Website www.estrellabio.com
- ESLA Profile on Yahoo Finance finance.yahoo.com/quote/ESLA
- ESLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/esla